{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:31:54Z","timestamp":1787070714896,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Female pattern hair loss (FPHL) is the most common hair loss disorder in women. Its origin is polygenic and multifactorial. Specific genetic factors predispose androgen receptors to be particularly sensitized so that they bind to circulating androgens, even with normal circulating levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The aim of this work was to evaluate and compare the efficacy and safety of topical spironolactone versus topical minoxidil in the treatment of FPHL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This prospective, simple randomized, comparative study was conducted on 80 female patients with FPHL. They were divided into two groups: Group (A): was subjected to topical spironolactone 1% gel application for 6 months, twice. Group (B): was subjected to topical minoxidil 5% gel application for 6 months, twice daily. The efficacy of treatment was assessed clinically by the Ludwig scale, Global Esthetic Improvement Scale, and trichoscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There was a statistically significant difference in improvement in both groups after treatment as regards: the Ludwig scale, Global Esthetic Improvement Scale, and Trichoscopy. In Group A: 10 patients had mild, 16 patients had moderate, two patients had excellent, and 12 had marked improvement. In Group B: 10 patients had mild, 14 patients had moderate, two patients had excellent, and 14 had marked improvement. Contact dermatitis, scalp irritation, and headache, which were more evident in Group B than in Group A.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Both topical spironolactone and topical minoxidil were cheap, safe, and effective lines for the treatment of FPHL with minimal and tolerable side effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijt.ijt_118_23","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T15:00:22Z","timestamp":1750690822000},"page":"42-50","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment of Female Pattern Hair Loss: A Comparative, Clinical, and Trichoscopic Study"],"prefix":"10.4103","volume":"17","author":[{"given":"Ghada Fawzy Rezk","family":"Hassan","sequence":"first","affiliation":[{"name":"Departments of Dermatology and Venereology and Pharmaceutical Technology, Faculties of Medicine and Pharmacy, Tanta University Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha Elsayed","family":"Elsaftawy","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Venereology and Pharmaceutical Technology, Faculties of Medicine and Pharmacy, Tanta University Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Yassin","family":"Mady","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Venereology and Pharmaceutical Technology, Faculties of Medicine and Pharmacy, Tanta University Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen Farouk","family":"Gheida","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Venereology and Pharmaceutical Technology, Faculties of Medicine and Pharmacy, Tanta University Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"R1-20250628","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaad.2018.08.062","article-title":"Androgens in women:Androgen-mediated skin disease and patient evaluation","volume":"80","author":"Bienenfeld","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R2-20250628","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.colsurfb.2016.05.042","article-title":"Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris:A randomized, double-blind, prospective trial","volume":"146","author":"Kelidari","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"R3-20250628","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.0022-202x.2001.01670.x","article-title":"Molecular mechanisms regulating hair follicle development","volume":"118","author":"Millar","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R4-20250628","doi-asserted-by":"crossref","first-page":"e13059","DOI":"10.1111\/dth.13059","article-title":"Physiopathology and current treatments of androgenetic alopecia:Going beyond androgens and anti-androgens","volume":"32","author":"Katzer","year":"2019","journal-title":"Dermatol Ther"},{"key":"R5-20250628","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/jdv.13455","article-title":"Towards a consensus on how to diagnose and quantify female pattern hair loss \u2013The 'female pattern hair loss severity index (FPHL-SI)'","volume":"30","author":"Harries","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R6-20250628","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/lsm.21059","article-title":"Combining confluent and fractionally ablative modalities of a novel 2790nm YSGG laser for facial resurfacing","volume":"43","author":"Munavalli","year":"2011","journal-title":"Lasers Surg Med"},{"key":"R7-20250628","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-4362.1996.tb02970.x","article-title":"Antiandrogen therapy in dermatology","volume":"35","author":"Shaw","year":"1996","journal-title":"Int J Dermatol"},{"key":"R8-20250628","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.det.2010.03.011","article-title":"Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss","volume":"28","author":"Rathnayake","year":"2010","journal-title":"Dermatol Clin"},{"issue":"Suppl 6","key":"R9-20250628","first-page":"S1","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men","volume":"9","author":"Blumeyer","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"R10-20250628","doi-asserted-by":"crossref","first-page":"e14678","DOI":"10.1111\/dth.14678","article-title":"A novel topical combination of minoxidil and spironolactone for androgenetic alopecia:Clinical, histopathological, and physicochemical study","volume":"34","author":"Abdel-Raouf","year":"2021","journal-title":"Dermatol Ther"},{"key":"R11-20250628","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.21608\/mjcu.2020.110836","article-title":"Topical finasteride versus topical spironolactone in the treatment of androgenetic alopecia","volume":"88","author":"Ahmed","year":"2020","journal-title":"Med J Cairo Univ"},{"key":"R12-20250628","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1111\/jocd.15328","article-title":"Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia:A cross sectional-comparative study","volume":"21","author":"Ammar","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"R13-20250628","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/09546634.2019.1654070","article-title":"Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia:A trichoscopic evaluation","volume":"32","author":"Ghonemy","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"R14-20250628","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1111\/jocd.14743","article-title":"Treatment with oral Vitamin D alone, topical minoxidil, or combination of both in patients with female pattern hair loss:A comparative clinical and dermoscopic study","volume":"21","author":"Hassan","year":"2022","journal-title":"J Cosmet Dermatol"}],"container-title":["International Journal of Trichology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_118_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:35:18Z","timestamp":1787067318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_118_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijt.ijt_118_23","relation":{},"ISSN":["0974-7753","0974-9241"],"issn-type":[{"value":"0974-7753","type":"print"},{"value":"0974-9241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2023-11-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}